On October 1, 2024, David Carter, President of the DRSS Division at Kratos Defense & Security Solutions Inc (KTOS, Financial), sold 4,000 shares of the company. The transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 115,129 shares of the company.
Kratos Defense & Security Solutions Inc specializes in providing advanced engineering, security, and surveillance systems to government and commercial clients. The company's offerings include unmanned systems, satellite communications, cybersecurity solutions, and missile defense systems.
Over the past year, the insider has sold a total of 8,000 shares and has not purchased any shares. This recent transaction is part of a broader trend observed within the company, where there have been 59 insider sells and only 2 insider buys over the past year.
Shares of Kratos Defense & Security Solutions Inc were trading at $23.68 on the day of the sale. The company has a market cap of $3.8 billion. The price-earnings ratio stands at 359.71, significantly higher than both the industry median of 35.37 and the company's historical median.
The stock is currently considered Significantly Overvalued according to the GF Value, with a price-to-GF-Value ratio of 1.35. The GF Value of $17.55 is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates.
This insider sale might interest investors tracking insider behaviors as an indicator of the company's future performance and valuation alignment.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.